Your browser doesn't support javascript.
loading
DNA-PKcs: A Targetable Protumorigenic Protein Kinase.
Dylgjeri, Emanuela; Knudsen, Karen E.
Affiliation
  • Dylgjeri E; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Knudsen KE; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cancer Res ; 82(4): 523-533, 2022 02 15.
Article in En | MEDLINE | ID: mdl-34893509
ABSTRACT
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a pleiotropic protein kinase that plays critical roles in cellular processes fundamental to cancer. DNA-PKcs expression and activity are frequently deregulated in multiple hematologic and solid tumors and have been tightly linked to poor outcome. Given the potentially influential role of DNA-PKcs in cancer development and progression, therapeutic targeting of this kinase is being tested in preclinical and clinical settings. This review summarizes the latest advances in the field, providing a comprehensive discussion of DNA-PKcs functions in cancer and an update on the clinical assessment of DNA-PK inhibitors in cancer therapy.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Biosynthesis / Gene Expression Regulation, Neoplastic / Energy Metabolism / DNA-Activated Protein Kinase / Immunity / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Biosynthesis / Gene Expression Regulation, Neoplastic / Energy Metabolism / DNA-Activated Protein Kinase / Immunity / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2022 Document type: Article